DocGo (DCGO) Competitors $4.92 -0.12 (-2.29%) As of 10:58 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends DCGO vs. ARDT, WGS, ADUS, PACS, PGNY, GRAL, NHC, AGL, FTRE, and CDNAShould you be buying DocGo stock or one of its competitors? The main competitors of DocGo include Ardent Health Partners (ARDT), GeneDx (WGS), Addus HomeCare (ADUS), PACS Group (PACS), Progyny (PGNY), Grail (GRAL), National HealthCare (NHC), agilon health (AGL), Fortrea (FTRE), and CareDx (CDNA). These companies are all part of the "healthcare" industry. DocGo vs. Ardent Health Partners GeneDx Addus HomeCare PACS Group Progyny Grail National HealthCare agilon health Fortrea CareDx Ardent Health Partners (NYSE:ARDT) and DocGo (NASDAQ:DCGO) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, community ranking, profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations. Do analysts rate ARDT or DCGO? Ardent Health Partners currently has a consensus price target of $21.55, indicating a potential upside of 44.74%. DocGo has a consensus price target of $6.10, indicating a potential upside of 21.27%. Given Ardent Health Partners' higher probable upside, research analysts clearly believe Ardent Health Partners is more favorable than DocGo.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ardent Health Partners 0 Sell rating(s) 2 Hold rating(s) 8 Buy rating(s) 2 Strong Buy rating(s) 3.00DocGo 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders hold more shares of ARDT or DCGO? 56.4% of DocGo shares are held by institutional investors. 2.7% of DocGo shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the media refer more to ARDT or DCGO? In the previous week, DocGo had 3 more articles in the media than Ardent Health Partners. MarketBeat recorded 7 mentions for DocGo and 4 mentions for Ardent Health Partners. Ardent Health Partners' average media sentiment score of 1.20 beat DocGo's score of 0.25 indicating that Ardent Health Partners is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ardent Health Partners 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DocGo 1 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community believe in ARDT or DCGO? DocGo received 28 more outperform votes than Ardent Health Partners when rated by MarketBeat users. However, 85.00% of users gave Ardent Health Partners an outperform vote while only 75.00% of users gave DocGo an outperform vote. CompanyUnderperformOutperformArdent Health PartnersOutperform Votes1785.00% Underperform Votes315.00%DocGoOutperform Votes4575.00% Underperform Votes1525.00% Which has higher earnings & valuation, ARDT or DCGO? Ardent Health Partners has higher revenue and earnings than DocGo. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioArdent Health Partners$5.41B0.39$53.90MN/AN/ADocGo$624.29M0.82$6.86M$0.2817.96 Is ARDT or DCGO more profitable? DocGo has a net margin of 4.35% compared to Ardent Health Partners' net margin of 0.00%. DocGo's return on equity of 8.90% beat Ardent Health Partners' return on equity.Company Net Margins Return on Equity Return on Assets Ardent Health PartnersN/A N/A N/A DocGo 4.35%8.90%5.72% SummaryDocGo beats Ardent Health Partners on 8 of the 15 factors compared between the two stocks. Get DocGo News Delivered to You Automatically Sign up to receive the latest news and ratings for DCGO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DCGO vs. The Competition Export to ExcelMetricDocGoHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$513.31M$938.85M$5.80B$9.11BDividend YieldN/A2.02%5.28%3.98%P/E Ratio17.9632.7725.9119.13Price / Sales0.823.87474.53119.58Price / Cash26.3026.7845.1138.24Price / Book1.723.067.655.12Net Income$6.86M-$5.50M$3.18B$245.96M7 Day Performance-9.21%-1.87%-0.49%-0.89%1 Month Performance16.71%8.02%1.84%-0.51%1 Year Performance43.71%114.45%18.66%16.50% DocGo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DCGODocGo1.2527 of 5 stars$4.92-2.3%$6.10+24.1%+40.1%$501.68M$624.29M17.564,164Upcoming EarningsGap UpARDTArdent Health PartnersN/A$14.79-1.7%$21.55+45.7%N/A$2.11B$5.41B0.0024,200Upcoming EarningsPositive NewsWGSGeneDx2.1012 of 5 stars$76.35-2.1%$70.67-7.4%+1,838.5%$2.10B$267.23M-24.551,200Earnings ReportAnalyst ForecastGap DownADUSAddus HomeCare4.7346 of 5 stars$113.22-2.0%$134.22+18.5%+22.3%$2.05B$1.06B25.9134,846Upcoming EarningsNews CoveragePositive NewsPACSPACS Group4.0524 of 5 stars$13.41-4.1%$34.00+153.5%N/A$2.04B$3.11B0.0032,433PGNYProgyny1.6173 of 5 stars$22.36+1.9%$25.83+15.5%-40.9%$1.90B$1.09B38.55310GRALGrail1.0469 of 5 stars$55.02+4.6%$16.00-70.9%N/A$1.85BN/A0.001,360Earnings ReportNews CoveragePositive NewsGap UpTrading HaltedHigh Trading VolumeNHCNational HealthCareN/A$102.76-0.8%N/AN/A$1.59B$1.23B12.8813,123Dividend AnnouncementAGLagilon health1.2525 of 5 stars$3.43-1.6%$4.03+17.6%-46.8%$1.41B$4.32B-3.641,117Upcoming EarningsFTREFortrea2.4054 of 5 stars$14.97-0.1%$23.30+55.6%-55.9%$1.34B$3.11B-4.3818,000CDNACareDx3.1165 of 5 stars$24.50-1.4%$28.33+15.6%+184.1%$1.31B$280.32M-9.07740Upcoming EarningsAnalyst DowngradeNews Coverage Related Companies and Tools Related Companies ARDT Alternatives WGS Alternatives ADUS Alternatives PACS Alternatives PGNY Alternatives GRAL Alternatives NHC Alternatives AGL Alternatives FTRE Alternatives CDNA Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:DCGO) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DocGo Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DocGo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
